CD4 and cancer: Similarly, TILs have been identified as indicators of favorable prognosis and reaction to treatment in various types of cancer, with higher expression levels of prognostic biomarkers (CD3+ TILs, CD4 + TILs and CD8+ TILs) also considered to indicative of improved overall survival in cases of human papillomavirus [38].